Back to Trades
MAIDA ANTHONY E III
DIRECTOR AND CMO - TRANS. MED.DirectorCIK 0001273213
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, MAIDA ANTHONY E III, DIRECTOR AND CMO - TRANS. MED., Director, has disclosed $0 in transactions — all concentrated in Oncotelic Therapeutics, Inc. (OTLC). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jul 14 | OTLC Oncotelic Therapeutics, Inc. | MAIDA ANTHONY E III | DIRECTOR AND CMO - TRANS. MED., Director | Award | $0 |
1 filing